Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gottlieb

Showing results (291-300 of 609) with videos related to

Pageof 61
Sort By:
JAMA Dermatology|May 7, 2015
CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical TrialAri M Goldminz, Mayte Suárez-Fariñas, Andrew C Wang, et al.
Neurotoxicity Research|April 28, 2004
Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptorV Panet-Raymond, B Gottlieb, L K Beitel, et al.
Experimental Neurology|October 10, 2006
Differential effects of water deprivation and rehydration on Fos and FosB/DeltaFosB staining in the rat brainstemLisa L Ji, Helmut B Gottlieb, Maurice L Penny, et al.
Archives of Dermatology|June 20, 2007
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasisStephen Tyring, Kenneth B Gordon, Yves Poulin, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|October 25, 2020
Report from the International Dermatology Outcome Measures InitiativeLourdes M Perez-Chada, Joseph F Merola, April W Armstrong, et al.
Cutis|September 15, 2015
Diffuse crusting of the skinNina C Botto, Erin H Penn, Bridget M Grant, et al.
The British Journal of Dermatology|January 4, 2007
Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasisB Elewski, C Leonardi, A B Gottlieb, et al.
Journal of the American Academy of Dermatology|September 25, 2001
Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasisM Lebwohl, L Drake, A Menter, et al.
Journal of Dietary Supplements|March 22, 2012
Resveratrol: potential as anticancer agentJulia Khristine Aluyen, Quynhanh N Ton, Thuytram Tran, et al.
The British Journal of Dermatology|March 15, 2012
Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extensionK Reich, J-P Ortonne, A B Gottlieb, et al.
Pageof 61

Showing results (291-300 of 609) with videos related to

Sort By:
Pageof 61
JAMA Dermatology|May 7, 2015
CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical TrialAri M Goldminz, Mayte Suárez-Fariñas, Andrew C Wang, et al.
Neurotoxicity Research|April 28, 2004
Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptorV Panet-Raymond, B Gottlieb, L K Beitel, et al.
Experimental Neurology|October 10, 2006
Differential effects of water deprivation and rehydration on Fos and FosB/DeltaFosB staining in the rat brainstemLisa L Ji, Helmut B Gottlieb, Maurice L Penny, et al.
Archives of Dermatology|June 20, 2007
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasisStephen Tyring, Kenneth B Gordon, Yves Poulin, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|October 25, 2020
Report from the International Dermatology Outcome Measures InitiativeLourdes M Perez-Chada, Joseph F Merola, April W Armstrong, et al.
Cutis|September 15, 2015
Diffuse crusting of the skinNina C Botto, Erin H Penn, Bridget M Grant, et al.
The British Journal of Dermatology|January 4, 2007
Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasisB Elewski, C Leonardi, A B Gottlieb, et al.
Journal of the American Academy of Dermatology|September 25, 2001
Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasisM Lebwohl, L Drake, A Menter, et al.
Journal of Dietary Supplements|March 22, 2012
Resveratrol: potential as anticancer agentJulia Khristine Aluyen, Quynhanh N Ton, Thuytram Tran, et al.
The British Journal of Dermatology|March 15, 2012
Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extensionK Reich, J-P Ortonne, A B Gottlieb, et al.
Pageof 61